Expertise in
16
conditions

Dr. Behnam B. Badie

Surgical Oncology
Duarte Cancer Center
1500 Duarte Rd, 
Duarte, CA 
Offers Telehealth
Expertise in
16
conditions
Duarte Cancer Center
1500 Duarte Rd, 
Duarte, CA 

Overview

Behnam Badie is a Surgical Oncologist practicing medicine in Duarte, California.

Dr. Badie is highly rated in 16 conditions, according to our data. His clinical expertise encompasses Gliomatosis Cerebri, Embryonal Tumor with Multilayered Rosettes, Pediatric Low-Grade Glioma (pLGG), Awake Craniotomy, and Gastrostomy.

He is actively involved in clinical research, co-authoring 69 peer reviewed articles and participating in 4 clinical trials.

Specialties

Surgical Oncology

Licenses

Neurological Surgery in CA

Languages Spoken

English

Gender

Male

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

Anthem BCBS
  • EPO
  • HMO
  • POS
  • PPO
Blue Shield of California
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE-MEDICAID PLAN
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
  • PPO
Medicaid
  • OTHER MEDICAID
  • STATE MEDICAID
UnitedHealthcare
  • EPO
  • HMO
  • POS
  • PPO
Wellcare
  • EPO
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE
  • OTHER MEDICARE PART D

Locations

Duarte Cancer Center
1500 Duarte Rd, Duarte, CA 91010

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

4 Clinical Trials

A Phase 1 Study to Evaluate Chimeric Antigen Receptor (CAR) T Cells With a Chlorotoxin Tumor-Targeting Domain for Patients With MMP2+ Recurrent or Progressive Glioblastoma
A Phase 1 Study to Evaluate Chimeric Antigen Receptor (CAR) T Cells With a Chlorotoxin Tumor-Targeting Domain for Patients With MMP2+ Recurrent or Progressive Glioblastoma
Enrollment Status: Active_not_recruiting
Publish Date: August 24, 2026
Intervention Type: Biological
Study Drug: Chlorotoxin (EQ)-CD28-CD3zeta-CD19t-expressing CAR T-lymphocytes
Study Phase: Phase 1
Phase I Study of Cellular ImmunoTx Using Memory Enriched T Cells Lentivirally Transduced to Express an IL13Rα2-Specific, Hinge-Optimized, 41BB-Costimulatory Chimeric Receptor and a Truncated CD19 for Pts With Rec/Ref MaligGlioma
Phase I Study of Cellular ImmunoTx Using Memory Enriched T Cells Lentivirally Transduced to Express an IL13Rα2-Specific, Hinge-Optimized, 41BB-Costimulatory Chimeric Receptor and a Truncated CD19 for Pts With Rec/Ref MaligGlioma
Enrollment Status: Active_not_recruiting
Publish Date: July 28, 2026
Intervention Type: Other, Biological, Procedure
Study Drugs: IL13Ralpha2-specific Hinge-optimized 4-1BB-co-stimulatory CAR/Truncated CD19-expressing Autologous TN/MEM Cells, IL13Ralpha2-specific Hinge-optimized 41BB-co-stimulatory CAR Truncated CD19-expressing Autologous T-Lymphocytes
Study Phase: Phase 1
A Phase 1 Study to Evaluate IL13Rα2-Targeted Chimeric Antigen Receptor (CAR) T Cells Combined With Checkpoint Inhibition for Patients With Resectable Recurrent Glioblastoma
A Phase 1 Study to Evaluate IL13Rα2-Targeted Chimeric Antigen Receptor (CAR) T Cells Combined With Checkpoint Inhibition for Patients With Resectable Recurrent Glioblastoma
Enrollment Status: Active_not_recruiting
Publish Date: May 14, 2026
Intervention Type: Other, Biological
Study Drugs: IL13Ralpha2-specific Hinge-optimized 4-1BB-co-stimulatory CAR/Truncated CD19-expressing Autologous TN/MEM Cells, Ipilimumab, Nivolumab
Study Phase: Phase 1
Phase I Study of Cellular Immunotherapy Using Memory-Enriched T Cells Lentivirally Transduced to Express a HER2-Specific, Hinge-Optimized, 41BB-Costimulatory Chimeric Receptor and a Truncated CD19 for Patients With Recurrent/Refractory Malignant Glioma
Phase I Study of Cellular Immunotherapy Using Memory-Enriched T Cells Lentivirally Transduced to Express a HER2-Specific, Hinge-Optimized, 41BB-Costimulatory Chimeric Receptor and a Truncated CD19 for Patients With Recurrent/Refractory Malignant Glioma
Enrollment Status: Active_not_recruiting
Publish Date: February 04, 2026
Intervention Type: Biological, Other, Procedure
Study Drug: HER2(EQ)BB?/CD19t+ T cells
Study Phase: Phase 1
View 3 Less Clinical Trials

69 Total Publications

Minimally Invasive Neurosurgical Robot for MRI-Guided Intratumoral Therapeutic Delivery.
Minimally Invasive Neurosurgical Robot for MRI-Guided Intratumoral Therapeutic Delivery.
Journal: IEEE transactions on medical robotics and bionics
Published: March 30, 2026
Similar Doctors
Expertise in
23
conditions
Dr. Yuman C. Fong
Surgical Oncology
Expertise in
23
conditions
Dr. Yuman C. Fong
Surgical Oncology
Referral may be required

Yuman Fong, M.D.

1500 Duarte Rd, 
Duarte, CA 
 (0.1 miles away)
800-826-4673
Experience:
42+ years
Languages Spoken:
English
Offers Telehealth

Yuman Fong is a Surgical Oncologist practicing medicine in Duarte, California. He has been practicing medicine for over 42 years. Dr. Fong is highly rated in 23 conditions, according to our data. His clinical expertise encompasses Cholangiocarcinoma (Bile Duct Cancer), Colorectal Cancer, Pancreatic Cancer, Hepatectomy, and Pancreatectomy.

Expertise in
22
conditions
Dr. Cristina R. Ferrone
Surgical Oncology
Expertise in
22
conditions
Dr. Cristina R. Ferrone
Surgical Oncology
Referral may be required

Susanne And Ervin Bard Pavilion

127 S San Vicente Blvd, 
Los Angeles, CA 
 (23.6 miles away)
310-423-5000
Languages Spoken:
English
See accepted insurances
Offers Telehealth

Cristina Ferrone is a Surgical Oncologist practicing medicine in Los Angeles, California. Dr. Ferrone is highly rated in 22 conditions, according to our data. Her clinical expertise encompasses Pancreatic Ductal Adenocarcinoma, Pancreatic Cancer, Cholangiocarcinoma (Bile Duct Cancer), Pancreatectomy, and Pancreaticoduodenectomy.

Expertise in
23
conditions
Dr. John H. Yim
Surgical Oncology
Expertise in
23
conditions
Dr. John H. Yim
Surgical Oncology
Referral may be required

John H. Yim, M.D.

1500 Duarte Rd, 
Duarte, CA 
 (0.1 miles away)
888-304-3959
Languages Spoken:
English
See accepted insurances
Offers Telehealth

John Yim is a Surgical Oncologist practicing medicine in Duarte, California. Dr. Yim is highly rated in 23 conditions, according to our data. His clinical expertise encompasses Breast Cancer, Inflammatory Breast Cancer, Thyroid Cancer, Thyroidectomy, and Thymectomy.

Frequently Asked Questions about Dr. Behnam B. Badie

How do I make an appointment with Dr. Behnam B. Badie?

You can book an appointment with Dr. Behnam B. Badie by calling their office at 866-486-1913. MediFind provides direct contact information so you can schedule visits, second opinions, or consultations without navigating third-party calendars.

Is Dr. Behnam B. Badie a top-rated expert for Gliomatosis Cerebri?

MediFind is an objective health platform that identifies experts based on real-world data. Dr. Behnam B. Badie is classified as an Elite expert for Gliomatosis Cerebri, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

What conditions does Dr. Behnam B. Badie specialize in?

While Dr. Behnam B. Badie is a Surgical Oncology, they have specific expertise in Gliomatosis Cerebri, Embryonal Tumor with Multilayered Rosettes, and Pediatric Low-Grade Glioma (pLGG). MediFind analyzes a doctor's articles and referral patterns to identify their specific areas of focus within Surgical Oncology.

Does Dr. Behnam B. Badie participate in research or clinical trials?

Yes. Dr. Behnam B. Badie has published 69 articles and abstracts on conditions like Gliomatosis Cerebri. You can view a list of Dr. Behnam B. Badie's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Does Dr. Behnam B. Badie accept my insurance?

Dr. Behnam B. Badie accepts most major insurance plans, including Anthem BCBS and Blue Shield of California. We recommend calling the office directly at 866-486-1913 to verify that your specific plan is currently accepted before your visit.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Badie's expertise for a condition
ConditionClose
View All 13 Advanced Conditions
View All 14 Experienced Conditions
Want to save this doctor for later?
Sign Up
Is this your doctor?
Find A Second Opinion
Not sure about your diagnosis?
Check Your Symptoms
 
 
 
 
Learn about our expert tiers
Learn More
Are you the provider on this profile?
Claim Profile